Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study

Elisabet Bergsten, AnnaCarin Horne, Maurizio Aricó, Itziar Astigarraga, R. Maarten Egeler, Alexandra H. Filipovich, Eiichi Ishii, Gritta Janka, Stephan Ladisch, Kai Lehmberg, Kenneth L. McClain, Milen Minkov, Scott Montgomery, Vasanta Nanduri, Diego Rosso, Jan-Inge Henter

Blood (2017) 130 (25): 2728–2738.

https://doi.org/10.1182/blood-2017-06-788349

Published: 2017

Journal Articles

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages

Blood (2016) 127 (22): 2672–2681.

https://doi.org/10.1182/blood-2016-01-690636

Published: 2016

Includes: Supplemental data

Journal Articles

Somatic activating ARAF mutations in Langerhans cell histiocytosis

David S. Nelson, Willemijn Quispel, Gayane Badalian-Very, Astrid G. S. van Halteren, Cor van den Bos, Judith V. M. G. Bovée, Sara Y. Tian, Paul Van Hummelen, Matthew Ducar, Laura E. MacConaill, R. Maarten Egeler, Barrett J. Rollins

Blood (2014) 123 (20): 3152–3155.

https://doi.org/10.1182/blood-2013-06-511139

Published: 2014

Includes: Supplemental data

Journal Articles

A Prospective Study on Incidence, Risk Factors and Long-Term Outcome of Osteonecrosis in 694 Patients with Pediatric Acute Lymphoblastic Leukemia,

Mariël L. te Winkel, MD, Rob Pieters, MD, PhD, Wim C.J. Hop, PhD, Hester A. de Groot-Kruseman, PhD, Maarten H. Lequin, MD, PhD, Inge M. van der Sluis, MD, PhD, Jos P.M. Bökkerink, MD, PhD, Jan A. Leeuw, MD, Marrie C. A. Bruin, MD, PhD, R. Maarten Egeler, MD, PhD, Anjo J.P. Veerman, MD, PhD, Marry M. van den Heuvel-Eibrink, MD, PhD

Blood (2011) 118 (21): 3578.

https://doi.org/10.1182/blood.V118.21.3578.3578

Published: 2011

Journal Articles

Reduction in Incidence of Severe Infections by Transplantation of High Doses of Haploidentical T Cells Selectively Depleted of Alloreactive Units

Denis-Claude Roy, MD, Mireille Guerin, MSc, Radia Sidi Boumedine, MSc, Silvy Lachance, MD, Sandra Cohen, MD, Guy Sauvageau, MD, PhD, Thomas Kiss, MD, Lambert Busque, MD, Jean Morin, Marie-Claude Guertin, PhD, Andrea Velardi, MD, PhD, Katayoun Rezvani, MD, PhD, Stephan Mielke, MD, R. Maarten Egeler, MD, PhD, A. John Barrett, MD, Claude Perreault, MD, Jean Roy, MD

Blood (2011) 118 (21): 3020.

https://doi.org/10.1182/blood.V118.21.3020.3020

Published: 2011

Journal Articles

Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol

Helena Trottestam, AnnaCarin Horne, Maurizio Aricò, R. Maarten Egeler, Alexandra H. Filipovich, Helmut Gadner, Shinsaku Imashuku, Stephan Ladisch, David Webb, Gritta Janka, Jan-Inge Henter, for the Histiocyte Society

Blood (2011) 118 (17): 4577–4584.

https://doi.org/10.1182/blood-2011-06-356261

Published: 2011

Includes: Supplemental data

Journal Articles

Photodepletion differentially affects CD4 + Tregs versus CD4 + effector T cells from patients with chronic graft-versus-host disease

Jean-Philippe Bastien, Gorazd Krosl, Cynthia Therien, Marissa Rashkovan, Christian Scotto, Sandra Cohen, David S. Allan, Donna Hogge, R. Maarten Egeler, Claude Perreault, Denis Claude Roy

Blood (2010) 116 (23): 4859–4869.

https://doi.org/10.1182/blood-2010-03-273193

Published: 2010

Includes: Supplemental data

Journal Articles

Early Intervention with Mesenchymal Stromal Cells for Refractory Grade III-IV Graft Versus Host Disease In Children Results In Excellent Long Term Outcome

Lynne Margaret Ball, MD, PhD, Maria E. Bernardo, MD, PhD, Jaap Jan Zwaginga, MD, PhD, Maarten van Tol, PhD, Angela Cometa, Helene Roelofs, PhD, Giovanna Giorgiani, Cornelia M Jol-van der Zijde, PhD, Maria Antonietta Avanzini, MD, Katarina Le Blanc, MD, PhD, Alice Bertaina, Francesco Frassoni, MD, Willem E. Fibbe, MD, PhD, Olle Ringden, MD, R. Maarten Egeler, MD, PhD, Franco Locatelli, MD, Arjan Lankester, MD, PhD

Blood (2010) 116 (21): 2336.

https://doi.org/10.1182/blood.V116.21.2336.2336

Published: 2010

Journal Articles

Novel Photodepletion Strategy to Preserve and Expand Tregs While Eliminating CD4+ Effector T Cells From Patients with Chronic Graft-Versus-Host Disease

Jean-Philippe Bastien, MSc, Gorazd Krosl, Ph.D, Cynthia Therien, BSc, MSc, Marissa Rashkovan, B.Sc, Christian Scotto, Ph.D, Sandra Cohen, MD, David S. Allan, MD, MSc, Donna E. Hogge, MD, PhD, R. Maarten Egeler, MD, Claude Perreault, MD, Denis-Claude Roy, MD

Blood (2010) 116 (21): 353.

https://doi.org/10.1182/blood.V116.21.353.353

Published: 2010

Journal Articles

Parents’ Commitment to Participation in Mesenchymal Stem Cell Donation and Research Demonstrates Extensive Altruism to Other Patients.

Anne-Marie Walraven, MSc, RN, Maria-Ester Bernardo, MD, Anneke Brand, MD, PhD, Helene Roelofs, PhD, Franco Locatelli, MD, PhD, R. Maarten Egeler, MD, PhD, Willem E. Fibbe, MD, PhD, Lynne M. Ball, MD

Blood (2007) 110 (11): 5078.

https://doi.org/10.1182/blood.V110.11.5078.5078

Published: 2007

Journal Articles

Co-Transplantation of HLA-Haploidentical, Bone Marrow Derived Mesenchymal Stem Cells Prevents Graft Failure and Improves Hematological Recovery in T-Cell Depleted Haploidentical Stem Cell Transplantation.

Lynne M. Ball, MD, Maria-Ester Bernardo, MD, Helene Roelofs, PhD, Arjan Lankester, MD, PhD, Angela Cometa, MD, R. Maarten Egeler, MD, PhD, Angela Cometa, MD, Giovanna Giorgiani, MD, Franco Locatelli, MD, PhD, Willem E. Fibbe, MD, PhD

Blood (2007) 110 (11): 3073.

https://doi.org/10.1182/blood.V110.11.3073.3073

Published: 2007

Journal Articles

Cotransplantation of ex vivo–expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation

Lynne M. Ball, Maria Ester Bernardo, Helene Roelofs, Arjan Lankester, Angela Cometa, R. Maarten Egeler, Franco Locatelli, Willem E. Fibbe

Blood (2007) 110 (7): 2764–2767.

https://doi.org/10.1182/blood-2007-04-087056

Published: 2007

Journal Articles

Co-Transplantation of Haploidentical Bone Marrow Derived Mesenchymal Stem Cells Overcomes Graft Dysfunction and Improves Hematological and Lymphocyte Recovery in Haploidentical Stem Cell Transplantation.

Lynne Margaret van Velzen-Ball, MD, Marie Ester Bernado, MD PhD, Franco Locatelli, MD PhD, Helene Roelofs, PhD, Arjan Lankester, MD PhD, R. Maarten Egeler, MD PhD, Willem E. Fibbe, MD PhD

Blood (2006) 108 (11): 3118.

https://doi.org/10.1182/blood.V108.11.3118.3118

Published: 2006

Journal Articles

A Human Anti-CD1a Monoclonal Antibody for Targeted Immunotherapy in Langerhans Cell Histiocytosis and Hematologic Malignancies.

Gitanjali Bechan, MD, David W. Lee, MS, R. Maarten Egeler, MD, PhD, Robert J. Arceci, MD, PhD

Blood (2005) 106 (11): 4815.

https://doi.org/10.1182/blood.V106.11.4815.4815

Published: 2005

Journal Articles

Possible link between unique chemokine and homing receptor expression at diagnosis and relapse location in a patient with childhood T-ALL

Nicola E. Annels, Annemieke J. Willemze, Vincent H. J. van der Velden, Claudia M. J. M. Faaij, Elisabeth van Wering, Daisy M. D. S. Sie-Go, R. Maarten Egeler, Maarten J. D. van Tol, Tom Révész

Blood (2004) 103 (7): 2806–2808.

https://doi.org/10.1182/blood-2003-06-1812

Published: 2004

Journal Articles

Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation

Jan-Inge Henter, AnnaCarin Samuelsson-Horne, Maurizio Aricò, R. Maarten Egeler, Göran Elinder, Alexandra H. Filipovich, Helmut Gadner, Shinsaku Imashuku, Diane Komp, Stephan Ladisch, David Webb, Gritta Janka

Blood (2002) 100 (7): 2367–2373.

https://doi.org/10.1182/blood-2002-01-0172

Published: 2002

Journal Articles

Differential In Situ Cytokine Profiles of Langerhans-Like Cells and T Cells in Langerhans Cell Histiocytosis: Abundant Expression of Cytokines Relevant to Disease and Treatment

R. Maarten Egeler, Blaise E. Favara, Marjan van Meurs, Jon D. Laman, Eric Claassen

Blood (1999) 94 (12): 4195–4201.

https://doi.org/10.1182/blood.V94.12.4195

Published: 1999

NARROW

Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages

Somatic activating ARAF mutations in Langerhans cell histiocytosis

A Prospective Study on Incidence, Risk Factors and Long-Term Outcome of Osteonecrosis in 694 Patients with Pediatric Acute Lymphoblastic Leukemia,

Reduction in Incidence of Severe Infections by Transplantation of High Doses of Haploidentical T Cells Selectively Depleted of Alloreactive Units

Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol

Photodepletion differentially affects CD4 + Tregs versus CD4 + effector T cells from patients with chronic graft-versus-host disease

Early Intervention with Mesenchymal Stromal Cells for Refractory Grade III-IV Graft Versus Host Disease In Children Results In Excellent Long Term Outcome

Novel Photodepletion Strategy to Preserve and Expand Tregs While Eliminating CD4+ Effector T Cells From Patients with Chronic Graft-Versus-Host Disease

Parents’ Commitment to Participation in Mesenchymal Stem Cell Donation and Research Demonstrates Extensive Altruism to Other Patients.

Co-Transplantation of HLA-Haploidentical, Bone Marrow Derived Mesenchymal Stem Cells Prevents Graft Failure and Improves Hematological Recovery in T-Cell Depleted Haploidentical Stem Cell Transplantation.

Cotransplantation of ex vivo–expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation

Co-Transplantation of Haploidentical Bone Marrow Derived Mesenchymal Stem Cells Overcomes Graft Dysfunction and Improves Hematological and Lymphocyte Recovery in Haploidentical Stem Cell Transplantation.

A Human Anti-CD1a Monoclonal Antibody for Targeted Immunotherapy in Langerhans Cell Histiocytosis and Hematologic Malignancies.

Possible link between unique chemokine and homing receptor expression at diagnosis and relapse location in a patient with childhood T-ALL

Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation

Differential In Situ Cytokine Profiles of Langerhans-Like Cells and T Cells in Langerhans Cell Histiocytosis: Abundant Expression of Cytokines Relevant to Disease and Treatment

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only